Literature DB >> 20789437

Methyldopa.

.   

Abstract

Entities:  

Year:  1962        PMID: 20789437      PMCID: PMC1958842     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

2.  Effect of alpha-methyl DOPA in severe and malignant hypertension.

Authors:  P J CANNON; R T WHITLOCK; R C MORRIS; M ANGERS; J H LARAGH
Journal:  JAMA       Date:  1962-03-03       Impact factor: 56.272

3.  The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.

Authors:  S M HESS; R H CONNAMACHER; M OZAKI; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

4.  Monoamine oxidase and decarboxylase inhibitors as antihypertensive agents.

Authors:  L GILLESPIE; A SJOERDSMA
Journal:  Med Clin North Am       Date:  1961-03       Impact factor: 5.456

5.  [Inhibition of serotonin formation by alpha-methyl-DOPA].

Authors:  E WESTERMANN; H BALZER; J KNELL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

6.  Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine.

Authors:  T L SOURKES
Journal:  Arch Biochem Biophys       Date:  1954-08       Impact factor: 4.013

7.  [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].

Authors:  F SCHAUB; F NAGER; H SCHAER; W ZIEGLER; P LICHTLEN
Journal:  Schweiz Med Wochenschr       Date:  1962-05-19

8.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728

9.  Agranulocytosis caused by methyl dopa (Aldomet).

Authors:  G P HALLWRIGHT
Journal:  N Z Med J       Date:  1961-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.